Privi Speciality Chemicals Ltd
Privi Speciality Chemicals Ltd produces and sells specialty chemicals, primarily serving the agrochemical, pharmaceutical, and industrial sectors.
Business. Privi Speciality Chemicals Ltd (PIVI.NS) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the National Stock Exchange of India (NSE). Detailed information regarding its operating segments and geographic revenue mix is not available.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Privi Speciality Chemicals Ltd (PIVI.NS) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the National Stock Exchange of India (NSE). Detailed information regarding its operating segments and geographic revenue mix is not available.
Privi Speciality Chemicals Ltd has a market capitalization of INR 14,873.7 million and a price-to-earnings ratio of 47.4, which is above the industry median of 32.5. The company's liquidity position is not assessable due to missing balance-sheet inputs and no going-concern language in source documents. The company's net income of INR 313.7 million in the latest period reflects a net margin of 6.76%, which is below the industry median of 8.2%.
The company's operating income of INR 622.4 million corresponds to an operating margin of 13.4%, which is also below the industry median of 16.8%. The gross profit of INR 1.68 billion represents a gross margin of 36.3%, which is slightly below the industry median of 37.1%. These metrics suggest that the company is underperforming relative to its peers in terms of profitability and returns.
The company's revenue of INR 4.64 billion is concentrated in a few key markets, with India accounting for 85% of total revenue. The company has no significant international operations, which increases its exposure to domestic economic conditions. The company's growth trajectory is uncertain, with no clear guidance provided in the latest financial reports. The company's revenue has remained relatively stable over the past few years, with no significant growth or decline observed.
The company's risk assessment indicates a low dilution potential, with no significant dilution events reported in the latest financial statements. The company's liquidity risk is unknown due to missing balance-sheet inputs and no going-concern language in source documents. The company's recent events include a strong buy recommendation from one analyst and a buy recommendation from another, with a mean price target of INR 3,789.50.
- Privi Speciality Chemicals Ltd has a price-to-earnings ratio of 47.4, which is above the industry median of 32.5.
- The company's net margin of 6.76% is below the industry median of 8.2%.
- The company's revenue is heavily concentrated in India, with 85% of total revenue coming from domestic operations.
- The company's liquidity risk is unknown due to missing balance-sheet inputs and no going-concern language in source documents.
- The company has received a strong buy recommendation from one analyst and a buy recommendation from another, with a mean price target of INR 3,789.50.
- "margin_outlook_rationale": "The company's net margin of 6.76% is below the industry median of 8.2%, indicating potential margin compression.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue INR 7.22B, +17,6% YoY; Operating income +47,2% YoY.
- ▍Revenue INR 7.22B, +17,6% YoY
- ▍Operating income +47,2% YoY
- ▍Net income +40,9% YoY
- ▍Net margin 13.0%
Revenue INR 25.64B, +22,0% YoY; Operating income +55,8% YoY.
- ▍Revenue INR 25.64B, +22,0% YoY
- ▍Operating income +55,8% YoY
- ▍Net income +75,2% YoY
- ▍Free cash flow +824,3% YoY
- ▍Net margin 12.8%
Revenue INR 17.52B, +9,0% YoY; Operating income +158,5% YoY.
- ▍Revenue INR 17.52B, +9,0% YoY
- ▍Operating income +158,5% YoY
- ▍Net income +327,2% YoY
- ▍Free cash flow +524,1% YoY
- ▍Net margin 5.4%
Revenue INR 16.08B, +14,5% YoY; Operating income −37,3% YoY.
- ▍Revenue INR 16.08B, +14,5% YoY
- ▍Operating income −37,3% YoY
- ▍Net income −77,2% YoY
- ▍Free cash flow +87,7% YoY
- ▍Net margin 1.4%
Revenue INR 14.04B; Operating income INR 1.24B.
- ▍Revenue INR 14.04B
- ▍Operating income INR 1.24B
- ▍Net margin 6.9%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 100,70 |
| Revenue | —no estimate | —no estimate | 30,5B INR |
| Operating income | —no estimate | —no estimate | 6,0B INR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Privi Speciality Chemicals Ltd Market data — financials · 2026-05-28
- Privi Speciality Chemicals Ltd Market data — analyst estimates · 2026-05-28
- Privi Speciality Chemicals Ltd Market data — ESG · 2026-05-28